Clinical Guideline Alerts – September 2024
A list of clinical practice guidelines and guideline summaries that were updated or published in September 2024.
Read More
InSights Hub
Miscellaneous
Showing 131 to 140 of 362
(Page 14)
Olaparib (LYNPARZA) – Guidelines+ Monographs
In this installment of our Guidelines+ Monographs Series, we will delve into the medication olaparib, marketed under the brand name Lynparza by AstraZeneca. Lynparza, is a poly ADP ribose polymerase (PARP) inhibitor for the treatment of ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. It was initially approved in 2014. In the following sections, […]
Read More
AAP’s Opioid Prescribing in Children and Adolescents – Guidelines Spotlight
The American Academy of Pediatrics (AAP) has recently published a clinical practice guideline (CPG) on Opioid Prescribing for Acute Pain Management in Children and Adolescents in Outpatient Settings. This marks a significant milestone for the AAP, as it is their inaugural CPG on opioid prescribing. The release of this guideline is particularly noteworthy given the […]
Read More
AACAP 2024 – Conference Preview on Attention Deficit Hyperactivity Disorder (ADHD)
The American Academy of Child and Adolescent Psychiatry (AACAP) Annual Meeting is scheduled to take place from October 14-19, 2024, in Seattle, Washington. This event is the largest gathering of child and adolescent psychiatrists worldwide, offering a unique opportunity to connect with and learn from colleagues and friends from over 60 countries. The AACAP’s 2024 […]
Read More
Upcoming FDA Decisions – October 2024
The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]
Read MoreAUA Seeks Reviewers for Genitourinary Syndrome of Menopause Guideline
The American Urological Association (AUA) is currently seeking peer reviewers for their upcoming guideline on Genitourinary Syndrome of Menopause. The draft of the guideline will be available for review in late October, with a two-week period allocated for assessment. Prior to receiving a copy of the draft guideline, all reviewers are required to disclose their […]
Read More
European Alliance of Associations for Rheumatology (EULAR) – Guidelines International Series
The European Alliance of Associations for Rheumatology (EULAR), previously known as the European League Against Rheumatism, is a leading pan-European organization dedicated to improving the lives of people with rheumatic and musculoskeletal diseases (RMDs) through research, education, and advocacy. Founded in 1947, EULAR supports scientific research, and provides educational resources for healthcare professionals and patients. […]
Read More
Comparing Pediatric Obesity Guidelines – Guidelines Side-By-Side (Childhood Obesity Awareness Month)
Childhood obesity is a prevalent chronic disease affecting children today, with a complex etiology involving genetic, physiological, environmental, and socioeconomic factors. The increase in childhood obesity rates in the United States has been significant, rising from approximately 5% in the 1960s to over 19% according to recent estimates. This condition greatly increases the risk of […]
Read MoreAGA’s First Guideline Utilizing AI is Now Open for Public Comment
The American Gastroenterological Association (AGA) has announced that their latest guideline, “AGA Clinical Practice Guideline on Computer-Aided-Detection Assisted Colonoscopy” is now open for public comment. This groundbreaking guideline represents AGA’s first comprehensive evaluation of the role of artificial intelligence (AI) in gastrointestinal care. This guideline’s intent is to assist healthcare practitioners by offering a detailed […]
Read More
AUA’s Salvage Therapy for Prostate Cancer – Guidelines Spotlight
The American Urological Association (AUA), in partnership with the American Society for Radiation Oncology and Society of Urologic Oncology, released in February 2024 a clinical guideline focusing on salvage therapy for recurrent prostate cancer. This three-part series guideline is designed to assist clinicians in making informed care decisions for patients who experience cancer recurrence following […]
Read More